论文部分内容阅读
目的 :探析盐酸氨溴索不同给药途径治疗小儿哮喘的临床运用效果。方法 :选择2012年10月-2013年9月期间我院收治的小儿哮喘患儿80例为研究对象,根据抓阄方法分为两组,两组均运用盐酸氨溴索治疗,其中对照组为静脉给药,观察组为雾化吸入,对比分析两组疗效。结果:观察组与对照组在治疗效果方面比较有统计学意义(P<0.05)。同时,观察组患儿的咳嗽时间为(8.76±0.85)d,肺部哮鸣音时间为(7.11±0.56)d;而对照组患儿的咳嗽时间为(10.21±1.52)d,肺部哮鸣音时间为(8.67±1.32)d,组间比较差异明显,具有统计学意义(P<0.05)。结论 :临床上给予小儿哮喘盐酸氨溴索雾化吸入治疗,不仅可以使治疗时间缩短,还能获得较好的疗效。
Objective: To investigate the clinical effect of different administration routes of ambroxol hydrochloride in children with asthma. Methods: Eighty children with pediatric asthma admitted to our hospital from October 2012 to September 2013 were selected and divided into two groups according to the grasping method. Both groups were treated with ambroxol hydrochloride, and the control group received intravenous Administration, observation group for inhalation, comparative analysis of two groups of curative effect. Results: The observation group and the control group in the treatment effect was statistically significant (P <0.05). At the same time, the cough time was (8.76 ± 0.85) days in the observation group and (7.11 ± 0.56) days in the lung. The cough time in the control group was (10.21 ± 1.52) days, The duration of the ringing was (8.67 ± 1.32) d, with significant difference between the two groups (P <0.05). Conclusion: Clinically, inhalation of ambroxol hydrochloride inhalation for pediatric asthma can not only shorten the treatment time, but also achieve better curative effect.